# Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension

> **NCT00657046** · PHASE2 · COMPLETED · sponsor: **Chelsea Therapeutics** · enrollment: 85 (actual)

## Conditions studied

- Intradialytic Hypotension

## Interventions

- **DRUG:** Droxidopa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00657046
- **Lead sponsor:** Chelsea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657046, "Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00657046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*